- Trials with a EudraCT protocol (168)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
168 result(s) found for: Diabetes AND Lantus (Insulin glargine) AND Insulin.
Displaying page 9 of 9.
| EudraCT Number: 2017-004454-42 | Sponsor Protocol Number: DIABMIND | Start Date*: 2018-04-27 | |||||||||||||||||||||
| Sponsor Name:Vall d'Hebron Research Institute | |||||||||||||||||||||||
| Full Title: English A pilot interventional study to arrest the progression of cognitive decline in diabetic patients at high risk of developing Alzheimer's disease by reducing hypoglycemic events. | |||||||||||||||||||||||
| Medical condition: Cognitive decline in patients affected with mild cognitive impairment | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
| EudraCT Number: 2015-004990-34 | Sponsor Protocol Number: MK-0431-845 | Start Date*: 2016-05-11 |
| Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc | ||
| Full Title: A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of the Continuation of Sitagliptin Compared with the Withdrawal of Sitagliptin... | ||
| Medical condition: Type 2 Diabetes Mellitus (T2DM) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: EE (Completed) HU (Completed) LV (Completed) CZ (Completed) ES (Completed) DK (Completed) RO (Completed) PL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2017-003296-60 | Sponsor Protocol Number: Oxidise | Start Date*: 2018-04-09 |
| Sponsor Name:University Hospital Tuebingen | ||
| Full Title: Empagliflozin effect on glucose toxicity in type 2 diabetes patients - a randomized, open-label, controlled, parallel group, exploratory study | ||
| Medical condition: Patients with T2DM aged 40 to 70 years (including) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-003298-40 | Sponsor Protocol Number: SCALES | Start Date*: 2014-12-15 |
| Sponsor Name:Instituto de Investigación La Fe | ||
| Full Title: STUDY OF THE EFFICACY AND SAFETY MANAGEMENT OF LIRAGLUTIDE IN TYPE 2 DIABETIC PATIENTS HOSPITALIZED WITH ACUTE CORONARY SYNDROME. IMPACT ON CARDIOVASCULAR RISK FACTOR. | ||
| Medical condition: TYPE 2 DIABETIC HOSPITALIZED PATIENTS WITH ACUTE CORONARY SYNDROME. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-000753-24 | Sponsor Protocol Number: DC2011LiBrain001 | Start Date*: 2011-10-13 | ||||||||||||||||
| Sponsor Name:VU University Medical Center | ||||||||||||||||||
| Full Title: Central effects of endogenous GLP-1 and the GLP-1 analog liraglutide on brain satiety and reward circuits and feeding behavior in diabetes. | ||||||||||||||||||
| Medical condition: diabetes mellitus obesity | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: NL (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2009-015396-27 | Sponsor Protocol Number: NCTU:ISRCTN52164803 | Start Date*: 2010-01-28 |
| Sponsor Name:Newcastle upon Tyne Hospitals NHS Foundation Trust | ||
| Full Title: Prevention of Recurrent Severe Hypoglycaemia: a Definitive RCT Comparing Optimised MDI and CSII with or without Adjunctive Real-time Continuous Glucose Monitoring. | ||
| Medical condition: Type 1 diabetes mellitus | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2011-005884-25 | Sponsor Protocol Number: 1553-B-211 | Start Date*: 2012-03-13 |
| Sponsor Name:Servicio de Endocrinologia y Nutricion. Hospital Universitari Bellvitge | ||
| Full Title: Study of the effectiveness of bariatric surgery in the treatment of type II Diabetes Mellitus in patients with grade I obesity | ||
| Medical condition: Diabetes mellitus 2 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2013-001473-24 | Sponsor Protocol Number: F3Z-MC-IOQL | Start Date*: 2014-02-05 | |||||||||||
| Sponsor Name:Eli Lilly and Company | |||||||||||||
| Full Title: An Individualized treatMent aPproach for oldER patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus | |||||||||||||
| Medical condition: Diabetes Mellitus, Type 2 | |||||||||||||
|
|||||||||||||
| Population Age: Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Prematurely Ended) DE (Prematurely Ended) AT (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
